ACADIA Pharmaceuticals Aktie [WKN: 603035 / ISIN: US0042251084]

Sende E-Mail

Analysen zur ACADIA Pharmaceuticals Inc.

08.07.2008ACADIA Pharmaceuticals UpgradeBanc of America Securities LLCneutal
18.06.2008ACADIA Pharmaceuticals sellBanc of America Securities LLCminus
17.06.2008ACADIA Pharmaceuticals DowngradeJefferies & Company Inc.neutal
17.06.2008ACADIA Pharmaceuticals DowngradeFriedman, Billings, Ramsey Group, Inc. neutal
17.06.2008ACADIA Pharmaceuticals DowngradeNeedham & Company, LLCneutal
06.05.2008ACADIA Pharmaceuticals sellBrean Murray, Carret & Co., LLCminus
12.12.2007ACADIA Pharmaceuticals strong buyJMP Securitiesplus
06.11.2007ACADIA Pharmaceuticals sellBrean Murray, Carret & Co., LLCminus
10.10.2007ACADIA Pharmaceuticals neues KurszielLehman Brothers Inc.plus
10.07.2007ACADIA Pharmaceuticals outperformFriedman, Billings Ramsey & Coplus
10.04.2007ACADIA Pharmaceuticals market outperformJMP Securitiesplus
11.01.2007ACADIA Pharmaceuticals DowngradeBrean Murrayneutal
14.12.2006ACADIA Pharmaceuticals buyNeedham & Coplus
02.11.2006ACADIA Pharmaceuticals buyBanc of America Sec.plus
11.07.2006ACADIA Pharmaceuticals strong buyBrean Murrayplus
10.07.2006Update ACADIA Pharmaceuticals Inc.: Strong BuyBrean Murrayplus
11.05.2006Update ACADIA Pharmaceuticals Inc.: OverweightLehman Brothersplus
01.12.2005Update ACADIA Pharmaceuticals Inc.: BuyBanc of America Sec.plus
17.10.2005Update ACADIA Pharmaceuticals Inc.: BuyAdams, Harkness & Hillplus




Wie bewerten Sie diese Seite?   sehr gut        schlecht
 

Anzeige